Torax Medical Inc this week announced the release of new data from the University of Southern California (USC), Keck Medical Center, an institution with expertise in diagnosis and treatment of gastroesophageal reflux disease (GERD). The retrospective study led by John C. Lipham, MD, compared the Linx Reflux Management System (Linx) to the standard of care, Laparoscopic Nissen Fundoplication (LNF) in similar patient populations. The results demonstrated Linx is as effective as LNF in controlling reflux but with less side effects. When compared to LNF for side effects, Linx patients reported less severe gas and bloating, while maintaining the ability to belch and vomit.

John C. Lipham, MD Chief, Division of Upper GI and General Surgery, associate professor of clinical surgery, Keck School of Medicine of USC says in a release, “This is the first propensity matched study comparing Linx to LNF assessing quality of life, proton-pump inhibitor (PPI) use, satisfaction, and complications. This study validates the Linx results shown in other studies and substantiates that Linx is as effective as LNF in controlling reflux. It further supports the use of Linx as a first line therapy in patients who are failing drugs to control their reflux.” The study results were published in the Journal of the American College of Surgeons.